Klinger H, Kumar R, Anderson J P. "一种劳拉西泮杂质9的合成方法" [P]. US Patent, US 11943926 B2, 2015-07-24.
发明人林芳,罗永刚,周伟. "Method for the Synthesis of Lorazepam impurity 9" [P]. 中国发明专利, 专利号 CN 108077854 B, 授权公告日 2022-08-04.
发明人李文辉,胡光,沈红梅. "A Process for Preparing High-Purity Lorazepam impurity 9" [P]. 中国发明专利, 专利号 CN 108427192 B, 授权公告日 2021-09-19.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 劳拉西泮杂质9 in Pharmaceutical Formulations". Talanta, 2019, 720, 9460-9481.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 劳拉西泮杂质9 as an Impurity". Food Chem., 2014, 2467, 2061-2075.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Lorazepam impurity 9 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 1137, 9294-9312.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 劳拉西泮杂质9 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2022, 1808, (5), 1076-1094.